Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Urologic Neoplasms 22. June 2024
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 8109  Previews Next
   
   Articles 1 - 20 / 162179  
   
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels.
Eur Urol Oncol
Mertens LS, Bruins HM, Contieri R, Babjuk M, Rai BP, Puig AC, Escrig JLD, Gontero P, van der Heijden AG, Liedberg F, Martini A, Masson-Lecomte A, Meijer RP, Mostafid H, Neuzillet Y, Pradere B, Redlef J, van Rhijn BWG, Rouanne M, RouprÍt M, SśbjÝrnsen S, Seisen T, Shariat SF, Soria F, Soukup V, Thalmann G, Xylinas E, Mariappan P, Alfred Witjes J.
PMID: 38906795 [PubMed - as supplied by publisher]


Diagnostic Accuracy of (18)F-Prostate Specific Membrane Antigen (PSMA) PET/CT Radiotracers in Staging and Restaging of Patients With High-Risk Prostate Cancer or Biochemical Recurrence: An Overview of Reviews.
Semin Nucl Med
Dullea A, O'Sullivan L, O'Brien KK, Carrigan M, Ahern S, McGarry M, Harrington P, Walsh KA, Smith SM, Ryan M.
PMID: 38906759 [PubMed - as supplied by publisher]


Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study).
J Nucl Med
Bauckneht M, Lanfranchi F, Albano D, Triggiani L, Linguanti F, Urso L, Mazzola R, Rizzo A, D'Angelo E, Dondi F, Mataj E, Pedersoli G, Abenavoli EM, Vaggelli L, Detti B, Ortolan N, Malorgio A, Guarneri A, Garrou F, Fiorini M, Grimaldi S, Ghedini P, Iorio GC, Iudicello A, Rovera G, Fornarini G, Bongiovanni D, Marcenaro M, Pazienza FM, Timon G, Salgarello M, Racca M, Bartolomei M, Panareo S, Ricardi U, Bertagna F, Alongi F, Barra S, Morbelli S, Sambuceti G, Belgioia L.
PMID: 38906557 [PubMed - as supplied by publisher]


Investigating angiogenin/ribonuclease 5 as a diagnostic biomarker for bladder cancer: In-depth analysis from a systematic review and meta-analysis.
Clin Biochem
Aalami AH, Abdeahad H, Aalami F, Sathyapalan T, Sahebkar A.
PMID: 38906363 [PubMed - as supplied by publisher]


The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Cancer Treat Rev
Zhang Y, Chen J, Liu H, Dai J, Zhao J, Zhu S, Zhang X, Liang J, Hu X, Zhao J, Liu Z, Shen P, Sun G, Zeng H.
PMID: 38905806 [PubMed - as supplied by publisher]


Bladder trigone sparing radiotherapy in prostate cancer treatment.
Radiography (Lond)
Chetiyawardana G, Chadwick E, Kordolaimi S, Sundar S.
PMID: 38905764 [PubMed - as supplied by publisher]


Molecular mechanism of ferroptosis and its application in the treatment of clear cell renal cell carcinoma.
Pathol Res Pract
Pan B, Kang J, Zheng R, Wei C, Zhi Y.
PMID: 38905897 [PubMed - as supplied by publisher]


Androgen Receptor Splice Variant 7 in Asian Patients With Metastatic Castration-Resistant Prostate Cancer.
JCO Precis Oncol
Ang D, Chan J, Ong WS, Tan HS, Ng QS, Yuen J, Chen K, Tay KJ, Wong SW, Saad M, Nagata M, Horie S, Chansriwong P, Ng CF, Wong A, Chua MLK, Toh CK, Tan MH, Lim T, Bhagat AAS, Kanesvaran R.
PMID: 38905583 [PubMed - indexed for MEDLINE]


A systematic review and meta-analysis of the role of perineal hydrodissection in perioperative, oncologic, and functional outcomes for patients undergoing robot-assisted radical prostatectomy.
J Robot Surg
Wang CJ, Chen CX, Liu Y, Wen Z, Li HY, Huang HT, Yang XS.
PMID: 38904929 [PubMed - indexed for MEDLINE]


Intermittent Catheterization Continuity Care on Bladder Function Recovery and Quality of Life in Patients After Radical Hysterectomy for Cervical Cancer: A Quasi-Experimental Study.
Int J Gen Med
Wang L, Wang F, Qin H, Hou L, Zhu S, He F, Zeng C.
PMID: 38903651 [PubMed]


Incidence of acute kidney injury and its associated risk factors in patients undergoing elective oesophagectomy surgeries at a tertiary care cancer institute - A pilot prospective observational study.
Indian J Anaesth
Parab SY, Majety SC, Ranganathan P, Jiwnani S, Pramesh CS, Shetmahajan M.
PMID: 38903259 [PubMed]


The association between healthy and unhealthy dietary indices with prostate cancer risk: a case-control study.
J Health Popul Nutr
Mahmoodi M, Gabal BC, Mohammadi F, Ibrahim FM, Jalilpiran Y, Nouri M, Faghih S.
PMID: 38902815 [PubMed - indexed for MEDLINE]


Development of an effective predictive screening tool for prostate cancer using the ClarityDX machine learning platform.
NPJ Digit Med
Hyndman ME, Paproski RJ, Kinnaird A, Fairey A, Marks L, Pavlovich CP, Fletcher SA, Zachoval R, Adamcova V, Stejskal J, Aprikian A, Wallis CJD, Pink D, Vasquez C, Beatty PH, Lewis JD.
PMID: 38902526 [PubMed]


Racial disparity in prostate cancer: an outlook in genetic and molecular landscape.
Cancer Metastasis Rev
Kaushal JB, Raut P, Muniyan S, Siddiqui JA, Alsafwani ZW, Seshacharyulu P, Nair SS, Tewari AK, Batra SK.
PMID: 38902476 [PubMed - as supplied by publisher]


The Role of Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
Eur Urol Oncol
Scilipoti P, , de Angelis M, Soria F, Pradere B, Krajewski W, D'Andrea D, Mari A, Giudice FD, Pichler R, Subiela JD, Afferi L, Albisinni S, Mertens L, Laukhtina E, Mori K, Radziszewski P, Shariat SF, Necchi A, Xylinas E, Gontero P, RouprÍt M, Montorsi F, Briganti A, Moschini M, European Association of Urology Young Academic Urologists Urothelial Carcinoma Working Group.
PMID: 38902138 [PubMed - as supplied by publisher]


Assessment and management of fracture risk in men with prostate cancer taking androgen deprivation therapy: a retrospective observational primary care database study.
Br J Gen Pract
Huang Q, Brown J, Mitchell C.
PMID: 38902070 [PubMed - indexed for MEDLINE]


First-Strike Rapid Predictive Dosimetry and Dose Response for (177)Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer.
J Nucl Med Technol
Kao YH, Falzone N, Pearson M, Sivaratnam D.
PMID: 38901967 [PubMed - as supplied by publisher]


Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies.
ESMO Open
Cursano MC, Valsecchi AA, Pantano F, Di Maio M, Procopio G, Berruti A, Bertoldo F, Tucci M, De Giorgi U, Santini D, Meet-URO and AIOM experts.
PMID: 38901175 [PubMed - as supplied by publisher]


Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma receiving first-line combination immunotherapies: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
ESMO Open
Takemura K, Yuasa T, Lemelin A, Ferrier E, Wells JC, Saad E, Saliby RM, Basappa NS, Wood LA, Jude E, Pal SK, Donskov F, Beuselinck B, Szabados B, Powles T, McKay RR, Gebrael G, Agarwal N, Choueiri TK, Heng DYC.
PMID: 38901174 [PubMed - as supplied by publisher]


Starving cancer cells to enhances DNA damage and immunotherapy response.
Oncotarget
Shahi A, Kidane D.
PMID: 38900609 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 162179    Page 1 of 8109  Previews Next

 
Rect Bottom
Adserver Footer
 

Username

Password

 

 

Forgot your username or password?

 

New User? Sign Up

Register to My Medline!

 

Learn more about the My Medline experience

more >>

  Time frame  
   

Sky right 1